De novo design and preparation of Copper(II)–based chemotherapeutic anticancer drug candidates with Boc–glycine and N,N–donor ligands: DNA binding, cleavage profile, and cytotoxic therapeutic response against MCF–7, PC–3, and HCT–116 cells

Suffora Akhter, Gursimar Kaur, Farukh Arjmand, Sartaj Tabassum